Literature DB >> 22703580

Combination of ADH1B*2/ALDH2*2 polymorphisms alters acetaldehyde-derived DNA damage in the blood of Japanese alcoholics.

Yoshiyuki Yukawa1, Manabu Muto, Kimiko Hori, Haruna Nagayoshi, Akira Yokoyama, Tsutomu Chiba, Tomonari Matsuda.   

Abstract

The acetaldehyde associated with alcoholic beverages is an evident carcinogen for the esophagus. Genetic polymorphisms of the alcohol dehydrogenase 1B (ADH1B) and aldehyde dehydrogenase 2 (ALDH2) genes are associated with the risk of esophageal cancer. However, the exact mechanism via which these genetic polymorphisms affect esophageal carcinogenesis has not been elucidated. ADH1B*2 is involved in overproduction of acetaldehyde due to increased ethanol metabolism into acetaldehyde, and ALDH2*2 is involved in accumulation of acetaldehyde due to the deficiency of acetaldehyde metabolism. Acetaldehyde can interact with DNA and form DNA adducts, resulting in DNA damage. N(2)-ethylidene-2'-deoxyguanosine (N(2)-ethylidene-dG) is the most abundant DNA adduct derived from acetaldehyde. Therefore, we quantified N(2)-ethylidene-dG levels in blood samples from 66 Japanese alcoholic patients using liquid chromatography/electrospray tandem mass spectrometry, and investigated the relationship between N(2)-ethylidene-dG levels and ADH1B and ALDH2 genotypes. The median N(2)-ethylidene-dG levels (25th percentile, 75th percentile) in patients with ADH1B*1/*1 plus ALDH2*1/*1, ADH1B*2 carrier plus ALDH2*1/*1, ADH1B*1/*1 plus ALDH2*1/*2, and ADH1B*2 carrier plus ALDH2*1/*2 were 2.14 (0.97, 2.37)/10(7) bases, 2.38 (1.18, 2.98)/10(7) bases, 5.38 (3.19, 6.52)/10(7) bases, and 21.04 (12.75, 34.80)/10(7) bases, respectively. In the ALDH2*1/*2 group, N(2)-ethylidene-dG levels were significantly higher in ADH1B*2 carriers than in the ADH1B*1/*1 group (P < 0.01). N(2)-ethylidene-dG levels were significantly higher in the ALDH2*1/*2 group than in the ALDH2*1/*1 group, regardless of ADH1B genotype (ADH1B*1/*1, P < 0.05; ADH1B*2 carriers, P < 0.01) N(2)-ethylidene-dG levels in blood DNA of the alcoholics was remarkably higher in individuals with a combination of the ADH1B*2 and ALDH2*2 alleles. These results provide a new perspective on the carcinogenicity of the acetaldehyde associated with alcoholic beverages, from the aspect of DNA damage.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22703580     DOI: 10.1111/j.1349-7006.2012.02360.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  22 in total

1.  Biomarkers of exposure and effect in human lymphoblastoid TK6 cells following [13C2]-acetaldehyde exposure.

Authors:  Benjamin C Moeller; Leslie Recio; Amanda Green; Wei Sun; Fred A Wright; Wanda M Bodnar; James A Swenberg
Journal:  Toxicol Sci       Date:  2013-02-19       Impact factor: 4.849

Review 2.  Role of alcohol in the development and progression of hepatocellular carcinoma.

Authors:  Iain H McKillop; Laura W Schrum; Kyle J Thompson
Journal:  Hepat Oncol       Date:  2015-11-30

3.  Impairment of aldehyde dehydrogenase 2 increases accumulation of acetaldehyde-derived DNA damage in the esophagus after ethanol ingestion.

Authors:  Yoshiyuki Yukawa; Shinya Ohashi; Yusuke Amanuma; Yukie Nakai; Mihoko Tsurumaki; Osamu Kikuchi; Shin'ichi Miyamoto; Tsunehiro Oyama; Toshihiro Kawamoto; Tsutomu Chiba; Tomonari Matsuda; Manabu Muto
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

4.  Transgenic mouse models for alcohol metabolism, toxicity, and cancer.

Authors:  Claire Heit; Hongbin Dong; Ying Chen; Yatrik M Shah; David C Thompson; Vasilis Vasiliou
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 5.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

6.  ALDH2 modulates autophagy flux to regulate acetaldehyde-mediated toxicity thresholds.

Authors:  Koji Tanaka; Kelly A Whelan; Prasanna M Chandramouleeswaran; Shingo Kagawa; Sabrina L Rustgi; Chiaki Noguchi; Manti Guha; Satish Srinivasan; Yusuke Amanuma; Shinya Ohashi; Manabu Muto; Andres J Klein-Szanto; Eishi Noguchi; Narayan G Avadhani; Hiroshi Nakagawa
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

Review 7.  Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency.

Authors:  Rachel A Montel; Carlos Munoz-Zuluaga; Katie M Stiles; Ronald G Crystal
Journal:  Cancer Gene Ther       Date:  2021-11-19       Impact factor: 5.854

8.  Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium.

Authors:  Yusuke Amanuma; Shinya Ohashi; Yoshiro Itatani; Mihoko Tsurumaki; Shun Matsuda; Osamu Kikuchi; Yukie Nakai; Shin'ichi Miyamoto; Tsunehiro Oyama; Toshihiro Kawamoto; Kelly A Whelan; Hiroshi Nakagawa; Tsutomu Chiba; Tomonari Matsuda; Manabu Muto
Journal:  Sci Rep       Date:  2015-09-16       Impact factor: 4.379

9.  Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2.

Authors:  Akira Yokoyama; Philip J Brooks; Tetsuji Yokoyama; Takeshi Mizukami; Shunsuke Shiba; Nobuhiro Nakamoto; Katsuya Maruyama
Journal:  Jpn J Clin Oncol       Date:  2017-04-01       Impact factor: 3.019

10.  Acetaldehyde exposure underlies functional defects in monocytes induced by excessive alcohol consumption.

Authors:  Shunsuke Shiba; Nobuhiro Nakamoto; Po-Sung Chu; Keisuke Ojiro; Nobuhito Taniki; Akihiro Yamaguchi; Rei Morikawa; Tadashi Katayama; Aya Yoshida; Ryo Aoki; Toshiaki Teratani; Takahiro Suzuki; Takeshi Miyamoto; Sachiko Hara; Akira Yokoyama; Takanori Kanai
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.